HOME › DRUGS › FOSAMPRENAVIR CALCIUM
ACTIVE SUBSTANCE / INN

FOSAMPRENAVIR CALCIUM

Brand name(s): FOSAMPRENAVIR CALCIUM, LEXIVA
FDA LISTED
PRESCRIPTION
DISCONTINUED
NONE (TENTATIVE APPROVAL)
NDA021548
ANDA204024
ACTIVE SUBSTANCE
Fosamprenavir Calcium
REGULATORS
FDA
SPONSORS / MAH
LUPIN LTD, SUN PHARM, VIIV HLTHCARE
TOTAL APPLICATIONS
3
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
FOSAMPRENAVIR CALCIUMANDA204130LUPIN LTDNone (Tentative Approval)
FOSAMPRENAVIR CALCIUMANDA204024SUN PHARMPrescription
LEXIVANDA021548VIIV HLTHCAREDiscontinued

FULL INTELLIGENCE ON FOSAMPRENAVIR CALCIUM

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →